ZA981175B - Phenyl xanthine esters and amides. - Google Patents

Phenyl xanthine esters and amides.

Info

Publication number
ZA981175B
ZA981175B ZA9801175A ZA981175A ZA981175B ZA 981175 B ZA981175 B ZA 981175B ZA 9801175 A ZA9801175 A ZA 9801175A ZA 981175 A ZA981175 A ZA 981175A ZA 981175 B ZA981175 B ZA 981175B
Authority
ZA
South Africa
Prior art keywords
amides
esters
xanthine
phenyl
phenyl xanthine
Prior art date
Application number
ZA9801175A
Other languages
English (en)
Inventor
Susan Mary Daluge
Gerald Wolberg
Douglas Alan Livingston
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA981175B publication Critical patent/ZA981175B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA9801175A 1997-02-14 1998-02-12 Phenyl xanthine esters and amides. ZA981175B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9703044.9A GB9703044D0 (en) 1997-02-14 1997-02-14 Phenyl xanthine esters and amides

Publications (1)

Publication Number Publication Date
ZA981175B true ZA981175B (en) 1999-08-12

Family

ID=10807635

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9801175A ZA981175B (en) 1997-02-14 1998-02-12 Phenyl xanthine esters and amides.

Country Status (37)

Country Link
US (3) US6355646B1 (cs)
EP (1) EP0970081B1 (cs)
JP (1) JP2001511792A (cs)
KR (1) KR100522639B1 (cs)
CN (1) CN1140527C (cs)
AP (1) AP1000A (cs)
AR (1) AR011441A1 (cs)
AT (1) ATE304542T1 (cs)
AU (1) AU754456B2 (cs)
BG (1) BG103722A (cs)
BR (1) BR9807682B1 (cs)
CA (1) CA2280730C (cs)
CO (1) CO4940444A1 (cs)
CZ (1) CZ298764B6 (cs)
DE (1) DE69831559T2 (cs)
DK (1) DK0970081T3 (cs)
EA (1) EA199900648A1 (cs)
EE (1) EE9900348A (cs)
ES (1) ES2249822T3 (cs)
GB (1) GB9703044D0 (cs)
HR (1) HRP980077A2 (cs)
HU (1) HU225962B1 (cs)
ID (1) ID22770A (cs)
IL (1) IL131179A (cs)
IS (1) IS5144A (cs)
MY (1) MY118545A (cs)
NO (1) NO325685B1 (cs)
NZ (1) NZ336923A (cs)
PE (1) PE58899A1 (cs)
PL (1) PL188018B1 (cs)
SK (1) SK110399A3 (cs)
TR (1) TR199901942T2 (cs)
TW (1) TW520371B (cs)
UA (1) UA57767C2 (cs)
WO (1) WO1998035966A1 (cs)
YU (1) YU38399A (cs)
ZA (1) ZA981175B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9703044D0 (en) * 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
GB9817623D0 (en) * 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
US6545002B1 (en) * 1999-06-01 2003-04-08 University Of Virginia Patent Foundation Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors
FR2804958B1 (fr) * 2000-02-15 2005-07-08 Hoechst Marion Roussel Inc Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
AU2002252134A1 (en) * 2001-02-28 2002-09-12 Smithkline Beecham Corporation Methods of treating irritable bowel syndrome and functional dyspepsia
US20080318983A1 (en) * 2001-11-09 2008-12-25 Rao Kalla A2b adenosine receptor antagonists
US7125993B2 (en) * 2001-11-09 2006-10-24 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US20040072848A1 (en) * 2002-02-26 2004-04-15 Huber Brian E Methods of treating irritable bowel syndrome and functional dyspepsia
CN101805343B (zh) * 2003-12-16 2014-04-16 尼克塔治疗亚拉巴马公司 化学改性的小分子
AU2012227249B2 (en) * 2003-12-16 2014-10-02 Nektar Therapeutics Chemically modified small molecules
US20060182692A1 (en) 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
WO2005102976A1 (en) * 2004-04-21 2005-11-03 Smithkline Beecham Corporation Process for preparing nonaethylene glycol monomethyl ether
RS52455B (sr) * 2004-09-01 2013-02-28 Gilead Sciences Inc. Postupak zarastanja rana primenom antagonista adenozinskog a2b receptora
US20070059740A1 (en) * 2005-08-26 2007-03-15 Linden Joel M Method of targeting a2b adenosine receptor antagonist therapy
US8193200B2 (en) * 2007-01-04 2012-06-05 University Of Virginia Patent Foundation Antagonists of A2B adenosine receptors for treatment of inflammatory bowel disease

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8510758D0 (en) * 1985-04-27 1985-06-05 Wellcome Found Compounds
US4968672A (en) 1987-01-02 1990-11-06 The United States Of America As Represented By The Department Of Health And Human Services Adenosine receptor prodrugs
US5015647A (en) 1987-04-24 1991-05-14 Burroughs Wellcome Co. Method for treating viral infections
GB8826595D0 (en) 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
GB8906792D0 (en) 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds
IL100088A (en) 1990-11-21 1995-07-31 Smithkline Beecham Corp FNT inhibitor preparations containing histogenic transducts converted at positions 1, 3, and 8
GB9210839D0 (en) 1992-05-21 1992-07-08 Smithkline Beecham Plc Novel compounds
TW252044B (cs) 1992-08-10 1995-07-21 Boehringer Ingelheim Kg
JP2613355B2 (ja) * 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
GB9415529D0 (en) * 1994-08-01 1994-09-21 Wellcome Found Phenyl xanthine derivatives
DE19535504A1 (de) 1995-09-25 1997-03-27 Bayer Ag Substituierte Xanthine
ES2185837T3 (es) * 1996-06-07 2003-05-01 Hoechst Ag Utilizacion de derivados de teofilina para el tratamiento y la profilaxis de las enfermedades de choque, nuevos compuestos de xantina y procedimientos para su produccion.
GB9703044D0 (en) * 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
US6117878A (en) 1998-02-24 2000-09-12 University Of Virginia 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
AU2640999A (en) 1998-02-26 1999-09-15 Zenyaku Kogyo Kabushiki Kaisha 1-azaindolizine derivatives
GB9817623D0 (en) * 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
RU2002119574A (ru) 1999-12-23 2004-01-10 Нитромед, Инк. (Us) Нитрозированные и нитрозилированные ингибиторы циклооксигеназы-2, композиции на их основе и способы их применения
US6751206B1 (en) * 2000-06-29 2004-06-15 Qualcomm Incorporated Method and apparatus for beam switching in a wireless communication system

Also Published As

Publication number Publication date
US20030181471A1 (en) 2003-09-25
HUP0000894A2 (hu) 2001-05-28
GB9703044D0 (en) 1997-04-02
KR20000071010A (ko) 2000-11-25
EP0970081A1 (en) 2000-01-12
YU38399A (sh) 2002-06-19
NO993915D0 (no) 1999-08-13
TR199901942T2 (xx) 1999-12-21
ATE304542T1 (de) 2005-09-15
HK1022907A1 (en) 2000-08-25
WO1998035966A1 (en) 1998-08-20
HUP0000894A3 (en) 2002-04-29
BR9807682B1 (pt) 2009-01-13
IL131179A (en) 2004-05-12
HRP980077A2 (en) 1998-12-31
AR011441A1 (es) 2000-08-16
JP2001511792A (ja) 2001-08-14
AP1000A (en) 2001-08-11
DE69831559T2 (de) 2006-06-14
CN1140527C (zh) 2004-03-03
CO4940444A1 (es) 2000-07-24
DK0970081T3 (da) 2006-02-06
EP0970081B1 (en) 2005-09-14
ES2249822T3 (es) 2006-04-01
SK110399A3 (en) 2000-06-12
IS5144A (is) 1999-07-30
CZ288799A3 (cs) 2000-04-12
CN1252071A (zh) 2000-05-03
TW520371B (en) 2003-02-11
HU225962B1 (en) 2008-01-28
US6437124B1 (en) 2002-08-20
PL335135A1 (en) 2000-04-10
CA2280730A1 (en) 1998-08-20
IL131179A0 (en) 2001-01-28
AP9901622A0 (en) 1999-09-30
EA199900648A1 (ru) 2000-04-24
UA57767C2 (uk) 2003-07-15
CA2280730C (en) 2006-10-10
NO325685B1 (no) 2008-07-07
BG103722A (en) 2000-06-30
DE69831559D1 (de) 2005-10-20
US6355646B1 (en) 2002-03-12
MY118545A (en) 2004-12-31
AU6622198A (en) 1998-09-08
CZ298764B6 (cs) 2008-01-23
AU754456B2 (en) 2002-11-14
US7002012B2 (en) 2006-02-21
PE58899A1 (es) 1999-06-17
BR9807682A (pt) 2000-02-15
KR100522639B1 (ko) 2005-10-19
NZ336923A (en) 2001-02-23
EE9900348A (et) 2000-02-15
PL188018B1 (pl) 2004-11-30
NO993915L (no) 1999-10-13
ID22770A (id) 1999-12-09

Similar Documents

Publication Publication Date Title
ZA977901B (en) Heterocyclic esters and amides.
EP1032377A4 (en) SUBSTITUTED 2-AMINOACETAMIDES AND APPLICATION THEREOF
EP1037635A4 (en) CONNECTIONS AROUND METHODS
ZA973503B (en) Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents.
AU6550098A (en) Nitrogen-containing oxyalkylene esters and uses thereof
HUP9700446A3 (en) Oilsuspension-concentrate and using thereof
ZA981175B (en) Phenyl xanthine esters and amides.
GB2325398B (en) Shelving
PL331523A1 (en) Azolotrizines and azolopyrimidines
HUP9801890A3 (en) Pyridyncarboxylic amides and esters and preparation thereof
PL341293A1 (en) Beta-lypothropin and application thereof
GB9725771D0 (en) Firearm and accessories
GR3035857T3 (en) Shelf
GB9601879D0 (en) Phenyl xanthine esters and amides
IL134499A0 (en) Pyrimidin-2- oxy-4-one and pyrimidin-2-oxy- 4-thione derivatives
GB9713881D0 (en) Shelf arrangement
GB9720258D0 (en) Extravise and Inavise
GB9708155D0 (en) Add and see
HUP9903447A3 (en) Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
GB9707590D0 (en) Sleep tight
PL106164U1 (en) Shelf
AU135087S (en) Shelf
GB9711414D0 (en) Shelf
TW333792U (en) Shelf
TW320185U (en) Multi-arc curve slidproof